Polyclonal Rabbit anti‑Rat GPA33 / A33 Antibody (Biotin, aa22‑235, WB) LS‑C689086
Polyclonal Rabbit anti‑Rat GPA33 / A33 Antibody (Biotin, aa22‑235, WB) LS‑C689086
Antibody:
GPA33 / A33 Rabbit anti-Rat Polyclonal (aa22-235) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
GPA33 / A33 Rabbit anti-Rat Polyclonal (aa22-235) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
A33 antibody LS-C689086 is a biotin-conjugated rabbit polyclonal antibody to A33 (GPA33) (aa22-235) from rat. It is reactive with mouse and rat. Validated for WB.
Target
Rat GPA33 / A33
Synonyms
GPA33 | A33 | Cell surface A33 antigen | Glycoprotein A33 | Transmembrane glycoprotein A33
Reactivity
Rat, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant GPA33 (Ile22-Ile235)
Specificity
The antibody is a rabbit polyclonal antibody raised against GPA33.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.05% Proclin-300, 50% glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, Western blot, Flow Cytometry, ELISA
Species:
Human
Applications:
IHC, Western blot, Flow Cytometry, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/21/2024